OBJECTIVE: To elucidate the regulatory mechanism of circRNAs in diabetic retinopathy. METHODS: Next-generation sequencing (NGS) was employed to identify circRNAs that are abnormally expressed in endothelial progenitor cells (EPCs) under hyperglycemia (HG) conditions. The regulatory mechanism and predicted targets of this circRNA were also studied via bioinformatics analysis, luciferase reporter assays, angiogenic differentiation experiments, flow cytometry, and RT-qPCR. RESULTS: Circ-astrotactin 1 (circ-Astn1) expression was decreased in EPCs under HG conditions, and circ-Astn1 overexpression inhibited HG-induced endothelial damage. The miR-138-5p and silencing information regulator 2 related enzyme 1 (SIRT1) were identified as circ-Astn1 downstream targets, which were further verified through luciferase reporter assays. SIRT1 silencing or miR-138-5p overexpression reversed the protective effect of circ-Astn1 on HG-induced endothelial cell dysfunction, as evidenced by increased apoptosis, abnormal vascular differentiation, and inflammatory factor secretion. SIRT1 overexpression reversed miR-138-5p-induced endothelial cell dysfunction under HG conditions. In vivo experiments confirmed that circ-Astn1 overexpression promoted skin wound healing through the regulation of SIRT1. CONCLUSIONS: These findings suggest that circ-Astn1 promotes SIRT1 expression by sponging miR-138-5p. Circ-Astn1 overexpression suppresses HG-induced endothelial cell damage via miR-138-5p/SIRT1 axis.
Overexpression of Circ-Astn1 Suppresses Hyperglycemia-Induced Endothelial Cell Damage via the miR-138-5p/SIRT1 Axis.
Circ-Astn1 的过表达通过 miR-138-5p/SIRT1 轴抑制高血糖诱导的内皮细胞损伤
阅读:6
作者:Yu Hong-Bin, Wang Li-Yun, Yan Xiao-Ning, Wu Xue-Yan, Wu Jian-Long, Liu Da-Wei, Liu Si-Yang
| 期刊: | Current Medical Science | 影响因子: | 1.500 |
| 时间: | 2025 | 起止号: | 2025 Feb;45(1):93-103 |
| doi: | 10.1007/s11596-025-00011-9 | 研究方向: | 细胞生物学 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
